APA (7th ed.) Citation

CP, S., A, L., S, D., ED, G., & P, S. (2012). Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: Frequent transmission by virally inactivated clotting factor concentrates. Transfusion, 52(7), 1482. https://doi.org/10.1111/j.1537-2995.2011.03420.x

Chicago Style (17th ed.) Citation

CP, Sharp, Lail A, Donfield S, Gomperts ED, and Simmonds P. "Virologic and Clinical Features of Primary Infection with Human Parvovirus 4 in Subjects with Hemophilia: Frequent Transmission by Virally Inactivated Clotting Factor Concentrates." Transfusion 52, no. 7 (2012): 1482. https://doi.org/10.1111/j.1537-2995.2011.03420.x.

MLA (9th ed.) Citation

CP, Sharp, et al. "Virologic and Clinical Features of Primary Infection with Human Parvovirus 4 in Subjects with Hemophilia: Frequent Transmission by Virally Inactivated Clotting Factor Concentrates." Transfusion, vol. 52, no. 7, 2012, p. 1482, https://doi.org/10.1111/j.1537-2995.2011.03420.x.